Fertility Treatment Cost: IVF and Insurance Gaps

A single IVF cycle — procedures, medications, and genetic testing combined — runs $15,000 to $30,000 out of pocket when insurance doesn’t cover it, and most American insurance plans still don’t. For households pursuing multiple cycles, the cumulative bill routinely exceeds $50,000 before a successful pregnancy. That number doesn’t include the downstream child-rearing cost — the United States Department of Agriculture’s Expenditures on Children by Families report (2015 data, released January 2017, the most recent edition available) puts the upper-income 18-year child-rearing cost at $372,210 in 2015 dollars, which inflates to roughly $495,000–$510,000 in 2025 dollars using Bureau of Labor Statistics CPI-U data. IVF is how that larger financial commitment begins for a growing share of families.

Key Figures at a Glance

Sources: American Society for Reproductive Medicine (ASRM); GoodRx market analysis, August 2025; ARC Fertility cost guide, 2024; FertilityIQ cost data; Segal/IFEBP analysis, February 2025.

What a Single IVF Cycle Actually Costs

The $12,400 figure the American Society for Reproductive Medicine cites for a base IVF cycle is a procedural floor — it covers egg retrieval and embryo transfer at the clinic but excludes virtually everything a real treatment cycle requires. Add fertility medications ($3,000–$7,000 per cycle), monitoring appointments, anesthesia, and lab fees, and the per-cycle total moves to $15,000–$30,000 depending on clinic, geography, and protocol, according to GoodRx’s 2025 analysis of national pricing data.

Geographic variation is not trivial. FertilityIQ data shows all-in IVF costs ranging from approximately $20,010 in Boston to more than $25,000 in Los Angeles for a single cycle. Clinics in major metro areas — New York, San Francisco, Chicago — consistently price toward the upper end of that range. Patients in smaller markets can find lower pricing, though clinical volume and success rates vary accordingly.

The cost structure has three distinct layers most billing summaries obscure. First, the base cycle fee — what the fertility center charges for ovarian stimulation monitoring, egg retrieval, fertilization, and embryo transfer. Second, fertility medications billed separately through specialty pharmacies; injectable gonadotropins like Gonal-F and Menopur drive most of this expense. Third, optional-but-common add-ons: preimplantation genetic testing for aneuploidy (PGT-A), embryo freezing, and frozen embryo transfer fees if a fresh transfer isn’t attempted in the same cycle.

Sources: American Society for Reproductive Medicine; GoodRx, August 2025; ARC Fertility, October 2024; FertilityIQ cost data; CNY Fertility, March 2026. Ranges reflect national averages; clinic- and geography-specific costs will differ.

PGT-A deserves specific attention for the $150k+ demographic because it’s both expensive and increasingly standard for women over 35. The test screens embryos for chromosomal abnormalities before transfer, and FertilityIQ reports it runs approximately $5,000 per cycle in the United States — split roughly evenly between the clinic embryo biopsy fee and the genetics laboratory testing fee. Because PGT-A results require embryos to be frozen while awaiting analysis, it automatically adds a frozen embryo transfer cycle and associated costs on top. The total add-on from electing PGT-A is typically $7,000–$11,000 above the base cycle, not $4,000–$6,000 as many patients initially budget.

The Multi-Cycle Reality: Why the Per-Cycle Price Is Misleading

SART’s 2022 national data — the most recent fully validated dataset — puts the live birth rate per intended egg retrieval at 43.1% for patients under 35, 31% for ages 35–37, and 19% for ages 38–40, per Contemporary OB/GYN’s analysis of the SART national summary report. For patients over 42, the rate drops to 3.2% per retrieval. These are per-cycle figures, not cumulative probabilities — meaning a 37-year-old has roughly a one-in-three shot per retrieval, which implies statistically expected costs across two or more cycles before a live birth.

Most patients require two to three cycles before achieving a successful pregnancy, according to RESOLVE: The National Infertility Association, and FertilityIQ’s patient data confirms this pattern. Running the math on a two-cycle scenario at national average all-in pricing — $15,000–$30,000 per cycle before genetic testing, roughly $24,000–$36,000 per cycle with PGT-A and FET — produces a realistic total treatment budget of $48,000 to $72,000 for two cycles with genetic testing. Three cycles pushes the range to $72,000–$108,000. The Segal analysis of IFEBP’s 2024 Employee Benefits Survey puts the average patient total near $50,000, consistent with a two-cycle scenario at the lower end of all-in pricing.

That per-patient cumulative figure is what the fertility industry rarely displays prominently. Clinics quote per-cycle costs; the math of multiple cycles and add-ons doesn’t appear until patients ask directly. For the full picture of what starting a family costs — beginning from before conception — the cost of having a child guide for $150k+ families covers the complete lifecycle including birth, childcare, and education funding.

The Insurance Gap: Where Coverage Exists and Where It Doesn’t

Twenty-five states and Washington, D.C., currently require some form of insurance coverage for fertility care, according to MultiState’s November 2025 analysis of state legislative activity. But “fertility coverage” and “IVF coverage” are not the same thing, and this distinction directly determines out-of-pocket exposure. Many state mandates cover only infertility diagnosis or less-expensive interventions like intrauterine insemination, not full IVF cycles.

Sources: MultiState analysis, November 2025; OneDigital, January 2026; Nava Benefits, February 2026; Cofertility, December 2025. State mandate details are subject to ongoing legislative change.

A critical structural limit applies regardless of state mandates: state insurance laws only reach fully insured plans — those where an insurance carrier assumes the risk. Self-insured employer plans, which cover the majority of employees at large corporations, are governed by federal ERISA law and are exempt from state benefit mandates entirely. A family in Massachusetts working for a self-insured employer gets no automatic IVF coverage benefit from the state’s otherwise strong mandate. Employer election is the operative variable, not state law.

Employer-sponsored fertility benefits are expanding. Nearly half of companies with 500 or more employees covered IVF in their broadest health plans in 2024, according to a Mercer survey cited by CNN — more than double the rate from 2019. Smaller employers lag significantly. For households earning $150k+, the first actionable step is reviewing the Summary Plan Description of their specific employer health plan — not the state mandate map — to understand actual IVF coverage terms, cycle limits, dollar caps, and diagnostic requirements. The hospital birth cost out-of-pocket breakdown covers a related gap most insured households underestimate once they do conceive.

The Overlooked Cost Driver: Medication Price Escalation

Standard IVF cost coverage focuses on clinic fees. What most analyses miss: fertility medication prices have risen 84% over the past decade, far outpacing the 37% average list-price increase across all prescription drugs over the same period, according to GoodRx’s List Price Index data reported in Drug Topics (April 2026). This means the medication component of IVF — already $3,000–$7,000 per cycle — has become structurally more expensive in real terms even as clinic procedural fees have remained relatively stable.

Injectable gonadotropins drive the majority of this cost. A single vial of Gonal-F can exceed $2,274 at retail; Menopur vials run approximately $316 each but require multiple vials per cycle, according to Gaia Family’s 2025 fertility drug cost guide. The typical ovarian stimulation protocol for IVF requires 8–12 days of injections, with most patients using multiple medications simultaneously. When the Trump administration announced the TrumpRx drug pricing initiative in late 2025, it specifically cited the three core IVF drugs — Gonal-F, Ovidrel, and Cetrotide — as costing approximately $5,000 per cycle combined, and targeted reductions of more than 70% through EMD Serono’s participation. Whether and how this materializes in actual patient billing will require monitoring through 2026.

For households comparing insurance plan options during open enrollment, the practical question isn’t just whether a plan covers IVF — it’s whether fertility medications are covered separately under the pharmacy benefit, and at what tier. A plan that covers the procedure but not the drugs still leaves a $3,000–$7,000 out-of-pocket gap per cycle. HSA and FSA funds are eligible for fertility treatment expenses including IVF medications, providing a pre-tax offset that can be meaningful at the $150k+ income level.

Finluxy 18-Year Child Cost Estimate

IVF is the front-end cost of having a child for many families. The backend cost — child-rearing through age 17 — is substantially larger. The Finluxy 18-Year Child Cost Estimate applies the United States Department of Agriculture’s (USDA) upper-income household figures from the Expenditures on Children by Families, 2015 report (Lino et al., released January 2017; the most recent edition in the series, as USDA discontinued annual publication after 2017) and adjusts for inflation using the Bureau of Labor Statistics CPI-U index.

Primary source: USDA Center for Nutrition Policy and Promotion, Expenditures on Children by Families, 2015, Miscellaneous Publication No. 1528-2015, January 2017. Inflation adjustment: BLS CPI-U. Note: USDA has not published an updated edition since 2017; this estimate represents the best available approximation using the authoritative primary source. Upper income is defined per 2015 USDA report as the upper third of the income distribution for married-couple families with children, approximately above $107,400 in 2015 dollars.

For a $150k+ household pursuing IVF before starting the child-rearing phase, the combined financial picture is material: $45,000–$75,000 in expected fertility treatment costs (two-cycle scenario), plus the Finluxy 18-Year Child Cost Estimate of $495,000–$510,000, puts the pre-college total commitment near $550,000–$600,000 in current dollars. That doesn’t include the college funding gap — the 529 plan savings analysis from birth covers what monthly contributions are required to fund a four-year private university education at current tuition trends. Nor does it include the income impact of parental leave for dual-income households, which represents a further real-dollar cost that rarely appears in standard child cost analyses.

How IVF Costs Compare to the Full Child Financial Picture

Framing IVF spending against the 18-year child-rearing cost for upper-income households is useful for calibrating priority. The $45,000–$75,000 fertility treatment outlay for a two-cycle scenario represents roughly 9–15% of the Finluxy 18-Year Child Cost Estimate — a significant but not dominant share of the total lifecycle commitment. Where it matters most financially is cash flow timing: fertility costs are front-loaded and concentrated in 12–24 months, while child-rearing costs spread over 18 years.

Households with a second child in mind face an additional consideration. USDA data shows that child-rearing cost per child declines for two-child families versus one-child families — housing in particular spreads across more children — but fertility treatment costs do not automatically scale down for subsequent cycles. The incremental cost of a second child analysis unpacks where economies of scale apply and where they don’t. Similarly, families who cannot achieve pregnancy through IVF may be considering adoption as an alternative — the domestic versus international adoption cost comparison provides a structured framework for that decision.

One figure worth tracking: the first-year baby budget begins immediately after a successful IVF pregnancy. For $150k+ households accustomed to planning in discrete financial phases, the transition from fertility spending to infant spending is abrupt. Both cost categories benefit from advance modeling.

What $150k+ Households Should Actually Evaluate

At the income level this analysis targets, IVF is rarely a question of can we afford it — it’s a question of how to structure it financially and whether employer benefits are being fully leveraged. Several concrete decision points follow from the cost data.

Open enrollment benefit audit. If your employer offers fertility benefits, verify whether the plan covers PGT-A and medications specifically. Many IVF benefit riders cover base procedures but exclude genetic testing and pharmacy costs — the two components where out-of-pocket exposure is highest. Nearly half of companies with 500+ employees covered IVF in their broadest health plans in 2024 (Mercer survey via CNN), but plan-to-plan variation is substantial.

HSA/FSA coordination. Fertility treatment expenses — including IVF procedures, medications, and related monitoring — qualify as IRS-eligible medical expenses for HSA and FSA purposes. At the $150k income level, maximizing HSA contributions ($4,300 for individuals, $8,550 for families in 2025) before IVF cycles begins provides a pre-tax offset. Given that medication costs alone can reach $7,000 per cycle, the tax savings on this component are meaningful.

Geographic arbitrage. FertilityIQ data shows a $5,000+ per-cycle cost differential between high-cost markets (Los Angeles, San Francisco) and mid-tier markets. For households with flexibility, selecting a clinic in a lower-cost metro within driving distance is legitimate financial optimization — provided success rates are comparable. SART’s publicly accessible clinic-level outcome data at SART.org allows apples-to-apples comparison of live birth rates by age group across participating clinics.

Tax deductibility threshold check. Medical expense deductions require out-of-pocket costs to exceed 7.5% of adjusted gross income (AGI) under current IRS rules. At $150,000 AGI, the threshold is $11,250. A two-cycle IVF scenario with out-of-pocket costs of $45,000–$75,000 would clear this threshold substantially, making the deduction worth pursuing — assuming expenses aren’t fully reimbursed by insurance or HSA. The child tax credit analysis at $150k–$400k income covers the downstream tax picture once a child is born.

Understanding the full lifetime cost context — from fertility treatment through the year-by-year child cost from ages 1 to 18 and ultimately college funding — is what separates reactive spending from planned financial commitment. The fertility treatment cost is one entry in a much larger ledger. Households that model it alongside the total financial difference between one and two children before beginning treatment are better positioned to make deliberate decisions about timing, scope of coverage, and long-term savings adjustments.